TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 148 filers reported holding TRANSLATE BIO INC in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $13,770,000 | -16.5% | 500,000 | -50.0% | 0.28% | -4.1% |
| Q1 2021 | $16,490,000 | -25.4% | 1,000,000 | -16.7% | 0.29% | -38.7% |
| Q4 2020 | $22,116,000 | +16.1% | 1,200,000 | -14.3% | 0.48% | +2.6% |
| Q3 2020 | $19,054,000 | -33.5% | 1,400,000 | -12.5% | 0.46% | -42.3% |
| Q2 2020 | $28,672,000 | +379.3% | 1,600,000 | +166.7% | 0.80% | +217.0% |
| Q1 2020 | $5,982,000 | +13.1% | 600,000 | -7.7% | 0.25% | +24.0% |
| Q4 2019 | $5,291,000 | -28.8% | 650,000 | -13.3% | 0.20% | -31.5% |
| Q3 2019 | $7,433,000 | -21.5% | 750,000 | 0.0% | 0.30% | -22.2% |
| Q2 2019 | $9,473,000 | +54.9% | 750,000 | +25.0% | 0.38% | +53.2% |
| Q1 2019 | $6,114,000 | +35.9% | 600,000 | 0.0% | 0.25% | +49.7% |
| Q4 2018 | $4,500,000 | -25.0% | 600,000 | 0.0% | 0.17% | +7.1% |
| Q3 2018 | $6,000,000 | -5.1% | 600,000 | +20.0% | 0.16% | +16.4% |
| Q2 2018 | $6,325,000 | – | 500,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,922,008 | $31,925,000 | 48.23% |
| Omega Fund Management, LLC | 2,437,603 | $19,842,000 | 6.32% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $17,768,000 | 2.98% |
| Baupost Group | 17,544,239 | $141,358,000 | 1.56% |
| RTW INVESTMENTS, LP | 3,304,808 | $26,901,000 | 1.02% |
| Camber Capital Management LP | 1,500,000 | $12,210,000 | 0.62% |
| DAFNA Capital Management LLC | 179,845 | $1,464,000 | 0.50% |
| Bain Capital Public Equity Management II, LLC | 416,670 | $3,392,000 | 0.32% |
| Rock Springs Capital Management LP | 950,000 | $7,733,000 | 0.24% |
| Artal Group S.A. | 650,000 | $5,291,000 | 0.20% |